Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$139.83 USD
-3.20 (-2.24%)
Updated May 2, 2024 04:00 PM ET
After-Market: $139.73 -0.10 (-0.07%) 6:12 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: -- |
6/2024 | $1.14 | 0.10% |
Earnings Summary
For their last quarter, Neurocrine Biosciences (NBIX) reported earnings of $0.42 per share, missing the Zacks Consensus Estimate of $1.04 per share. This reflects a negative earnings surprise of 59.62%. Look out for NBIX's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of $1.14 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for NBIX
Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates
NBIX: What are Zacks experts saying now?
Zacks Private Portfolio Services